DME Capital Management’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History

DME Capital Management’s Portfolio NUVB.WS Stock Details NUVB.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-100,000	Closed	-$33K	–	50
2025 Q4	$33K	Hold	100,000	–	–	﹤0.01%	40
2025 Q3	$20.2K	Hold	100,000	–	–	﹤0.01%	36
2025 Q2	$27K	Hold	100,000	–	–	﹤0.01%	33
2025 Q1	$32K	Hold	100,000	–	–	﹤0.01%	32
2024 Q4	$23K	Hold	100,000	–	–	﹤0.01%	35
2024 Q3	$9.79K	Hold	100,000	–	–	﹤0.01%	37
2024 Q2	$16K	Hold	100,000	–	–	﹤0.01%	38
2024 Q1	$30.3K	Buy	+100,000	New	+$11.9K	﹤0.01%	41

DME Capital Management's NUVB.WS Position: Q1 2026 in Review

DME Capital Management sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q1 2026, closing a stake of 100,000 shares — an estimated $33K sold.

DME Capital Management first reported a position in NUVB.WS in Q1 2024 and held it in 8 quarters. The position peaked at $33K in Q4 2025. 0 funds tracked by Wall St. Rank hold NUVB.WS as of Q1 2026.

DME Capital Management reported no remaining Nuvation Bio Inc Warrants position as of Q1 2026 after selling out during the quarter.
DME Capital Management sold 100,000 Nuvation Bio Inc Warrants shares in Q1 2026, an estimated $33K.
DME Capital Management first reported a position in Nuvation Bio Inc Warrants in Q1 2024 and held it in 8 quarters.
DME Capital Management's Nuvation Bio Inc Warrants position peaked at $33K in Q4 2025.
0 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q1 2026.

Based on DME Capital Management's 13F filing for Q1 2026, filed 15 May 2026.